Trulieve's NYSE debut lifted ancillary suppliers and fertilizer plays by mid-single digits while multi-state operators drifted or sold off, exposing a liquidity gap that persists even after the first exchange uplist under the Trump administration's cancer-research carveout.

Read the full US brief for 2026-07-13.